Reaction Details |
| Report a problem with these data |
Target | Neutrophil cytosol factor 1 [S99G] |
---|
Ligand | BDBM55391 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Dose Response Confirmation for small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs) |
---|
IC50 | 5280±n/a nM |
---|
Citation | PubChem, PC Dose Response Confirmation for small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs) PubChem Bioassay(2008)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Neutrophil cytosol factor 1 [S99G] |
---|
Name: | Neutrophil cytosol factor 1 [S99G] |
Synonyms: | NCF1 | NCF1_HUMAN | NOXO2 | SH3PXD1A | neutrophil cytosolic factor 1 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 44664.39 |
Organism: | Homo sapiens (Human) |
Description: | gi_115298672 |
Residue: | 390 |
Sequence: | MGDTFIRHIALLGFEKRFVPSQHYVYMFLVKWQDLSEKVVYRRFTEIYEFHKTLKEMFPI
EAGAINPENRIIPHLPAPKWFDGQRAAENRQGTLTEYCGTLMSLPTKISRCPHLLDFFKV
RPDDLKLPTDNQTKKPETYLMPKDGKSTATDITGPIILQTYRAIANYEKTSGSEMALSTG
DVVEVVEKSESGWWFCQMKAKRGWIPASFLEPLDSPDETEDPEPNYAGEPYVAIKAYTAV
EGDEVSLLEGEAVEVIHKLLDGWWVIRKDDVTGYFPSMYLQKSGQDVSQAQRQIKRGAPP
RRSSIRNAHSIHQRSRKRLSQDAYRRNSVRFLQQRRRQARPGPQSPGSPLEEERQTQRSK
PQPAVPPRPSADLILNRCSESTKRKLASAV
|
|
|
BDBM55391 |
---|
n/a |
---|
Name | BDBM55391 |
Synonyms: | 1-[3-[1,1-bis(4-methoxyphenyl)but-1-en-2-yl]-1-indolyl]-3-(4-methyl-1-piperazinyl)-2-propanol | 1-[3-[1,1-bis(4-methoxyphenyl)but-1-en-2-yl]indol-1-yl]-3-(4-methylpiperazin-1-yl)propan-2-ol | 1-[3-[1-ethyl-2,2-bis(4-methoxyphenyl)vinyl]indol-1-yl]-3-(4-methylpiperazino)propan-2-ol | 1-{3-[1-ethyl-2,2-bis(4-methoxyphenyl)vinyl]-1H-indol-1-yl}-3-(4-methyl-1-piperazinyl)-2-propanol | MLS000533166 | SMR000140604 | cid_2859666 |
Type | Small organic molecule |
Emp. Form. | C34H41N3O3 |
Mol. Mass. | 539.7076 |
SMILES | [#6]-[#6]\[#6](=[#6](/c1ccc(-[#8]-[#6])cc1)-c1ccc(-[#8]-[#6])cc1)-c1cn(-[#6]-[#6](-[#8])-[#6]-[#7]-2-[#6]-[#6]-[#7](-[#6])-[#6]-[#6]-2)c2ccccc12 |
Structure |
|